Literature DB >> 11340068

BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: a unique role for proHB-EGF in cell survival regulation.

J Lin1, L Hutchinson, S M Gaston, G Raab, M R Freeman.   

Abstract

Several cell functions related to growth and survival regulation have been attributed specifically to the membrane form of heparin-binding EGF-like growth factor (proHB-EGF), rather than to the diffusible, processed HB-EGF isoform. These findings suggest the existence of a functional binding partner specifically for the membrane form of the growth factor. In this study we have identified the prosurvival cochaperone, BAG-1, as a protein that interacts with the cytoplasmic tail domain of proHB-EGF. Interaction between BAG-1 and the 24-amino acid proHB-EGF cytoplasmic tail was initially identified in a yeast two-hybrid screen and was confirmed in mammalian cells. The proHB-EGF tail bound BAG-1 in an hsp70-independent manner and within a 97-amino acid segment that includes the ubiquitin homology domain in BAG-1 but does not include the hsp70 binding site. Effects of BAG-1 and proHB-EGF co-expression were demonstrated in cell adhesion and cell survival assays and in quantitative assays of regulated secretion of soluble HB-EGF. Because the BAG-1 binding site is not present on the mature, diffusible form of the growth factor, these findings suggest a new mechanism by which proHB-EGF, in isolation from the diffusible form, can mediate cell signaling events. In addition, because effects of BAG-1 on regulated secretion of soluble HB-EGF were also identified, this interaction has the potential to alter the signaling capabilities of both the membrane-anchored and the diffusible forms of the growth factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11340068     DOI: 10.1074/jbc.M010237200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  MYC and the control of apoptosis.

Authors:  Steven B McMahon
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

2.  Epidermal growth factor (EGF) ligand release by substrate-specific a disintegrin and metalloproteases (ADAMs) involves different protein kinase C (PKC) isoenzymes depending on the stimulus.

Authors:  Michelle Dang; Karen Dubbin; Antonio D'Aiello; Monika Hartmann; Harvey Lodish; Andreas Herrlich
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

3.  Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells.

Authors:  Yu Zhou; Gail E Besner
Journal:  Neurosignals       Date:  2010-09-16

4.  The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells.

Authors:  Aleksandra Glogowska; Janette Pyka; Astrid Kehlen; Marek Los; Paul Perumal; Ekkehard Weber; Sheue-yann Cheng; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

5.  Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes.

Authors:  Chun-Liang Chen; Veela B Mehta; Hong-Yi Zhang; Dana Wu; Iyore Otabor; Andrei Radulescu; Osama N El-Assal; Jiexiong Feng; Yan Chen; Gail E Besner
Journal:  Growth Factors       Date:  2010-04       Impact factor: 2.511

6.  Human BAG-1 proteins bind to the cellular stress response protein GADD34 and interfere with GADD34 functions.

Authors:  Wesley J Hung; Rachel S Roberson; Jaime Taft; Daniel Y Wu
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

7.  Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitin-proteasome pathway in human cancer cells.

Authors:  Aleksandra Glogowska; Jörg Stetefeld; Ekkehard Weber; Saeid Ghavami; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

8.  Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo.

Authors:  Kunlin Jin; Xiao Ou Mao; Yunjuan Sun; Lin Xie; Lan Jin; Eiichiro Nishi; Michael Klagsbrun; David A Greenberg
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

9.  [Clinical and genetic findings in a patient with fundus albipunctatus].

Authors:  K Rüther; B P M Janssen; U Kellner; J J M Janssen; M Bohne; J Reimann; C A G G Driessen
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

10.  Ectodomain cleavage of the EGF ligands HB-EGF, neuregulin1-beta, and TGF-alpha is specifically triggered by different stimuli and involves different PKC isoenzymes.

Authors:  Andreas Herrlich; Eva Klinman; Jonathan Fu; Cameron Sadegh; Harvey Lodish
Journal:  FASEB J       Date:  2008-08-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.